Ishita Drugs and Industries Limited (BOM:524400)
India flag India · Delayed Price · Currency is INR
74.85
+0.86 (1.16%)
At close: Feb 12, 2026

BOM:524400 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
161.68149.97151.88120.72140.9139.49
Revenue Growth (YoY)
8.30%-1.25%25.80%-14.32%1.01%-5.96%
Cost of Revenue
135.33126.13129.37100.12118.14119.29
Gross Profit
26.3623.8522.520.622.7620.2
Selling, General & Admin
13.8413.8313.4212.9811.8511.02
Other Operating Expenses
2.890----
Operating Expenses
17.8214.9314.5314.2813.1512.48
Operating Income
8.548.927.976.329.617.72
Interest Expense
-0.47-0.35-0.62-0.37-0.04-0.19
Interest & Investment Income
3.363.362.82.011.063.14
Other Non Operating Income (Expenses)
0.41-0.38-0.28-0.17-0.2-0.13
Pretax Income
11.8411.559.877.7910.4310.54
Income Tax Expense
2.952.872.392.022.382.24
Net Income
8.898.687.495.778.058.3
Net Income to Common
8.898.687.495.778.058.3
Net Income Growth
3.13%15.98%29.63%-28.27%-2.97%51.64%
Shares Outstanding (Basic)
333333
Shares Outstanding (Diluted)
333333
EPS (Basic)
2.972.902.501.932.692.77
EPS (Diluted)
2.972.902.501.932.692.77
EPS Growth
3.12%16.00%29.53%-28.25%-2.89%51.40%
Free Cash Flow
--38.2120.94-30.3230.58-6.8
Free Cash Flow Per Share
--12.787.00-10.1410.23-2.27
Gross Margin
16.30%15.90%14.82%17.07%16.16%14.48%
Operating Margin
5.28%5.95%5.25%5.24%6.82%5.53%
Profit Margin
5.50%5.79%4.93%4.78%5.71%5.95%
Free Cash Flow Margin
--25.48%13.79%-25.11%21.70%-4.87%
EBITDA
9.6310.019.087.6210.919.18
EBITDA Margin
5.95%6.68%5.98%6.31%7.74%6.58%
D&A For EBITDA
1.081.11.121.291.31.46
EBIT
8.548.927.976.329.617.72
EBIT Margin
5.28%5.95%5.25%5.24%6.82%5.53%
Effective Tax Rate
24.89%24.85%24.18%25.92%22.82%21.27%
Revenue as Reported
165.83153.33154.68122.73141.97142.63
Advertising Expenses
-0.020.020.150.040.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.